We work with the medical community to transform the lives of patients through the best scientific, management and leadership talent worldwide.
OTC drug makers, private research institutes, device manufacturers and others across the life science spectrum benefit from Boyden’s specialised expertise in meeting distinct talent needs.
The survey aims to understand the outlook around demand and availability of executive talent, global mobility, time to recruit, remuneration and a breakdown of growth potential by sector.
Our discussion with Ray Pisani, President & CEO of Alberta Blue Cross on leadership, motivation, and the value of diversity.
CEO Vas Narasimhan seeks to transform the Swiss multinational into a cutting-edge pharmaceuticals firm that embraces digital healthcare technology.
Lower volumes, higher biotech industry costs, and the departure of big pharmaceutical companies from the field thwart development of new antibiotics.
Boyden’s Trevor Pritchard and Steve Nilsen placed Amy Efantis as new President and Chief Executive Officer of the Plasma Therapeutics Association (PPTA).